Auxilium and Pfizer amend Xiapex collaboration agreement
As a result of the modification, the Collaboration Agreement will terminate no later than 24 April 2013 and the companies will continue to perform all the obligations as
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.